Genfit S.A. (GNFTF)
USD 3.54
(-36.22%)
USD 3.54
(-36.22%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 173.87 Million EUR | -24.44% |
| 2022 | 230.1 Million USD | -28.01% |
| 2021 | 319.63 Million USD | 32.32% |
| 2020 | 241.56 Million USD | -30.55% |
| 2019 | 347.8 Million USD | 32.59% |
| 2018 | 262.32 Million USD | -25.49% |
| 2017 | 352.05 Million USD | 100.95% |
| 2016 | 175.19 Million USD | 133.25% |
| 2015 | 75.11 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 207.87 Million USD | 0.0% |
| 2023 Q2 | 210.82 Million USD | 0.24% |
| 2023 Q3 | 183.81 Million USD | -12.81% |
| 2023 Q4 | 173.87 Million EUR | -5.41% |
| 2023 Q1 | 210.33 Million USD | -8.59% |
| 2023 FY | 173.87 Million EUR | -24.44% |
| 2022 Q2 | 247.95 Million USD | 0.0% |
| 2022 FY | 230.1 Million USD | -28.01% |
| 2022 Q3 | 211.21 Million USD | -14.82% |
| 2022 Q4 | 230.1 Million USD | 8.95% |
| 2021 Q2 | 157.8 Million USD | 0.0% |
| 2021 FY | 319.63 Million USD | 32.32% |
| 2021 Q4 | 319.63 Million USD | 0.0% |
| 2020 Q2 | 287.75 Million USD | 0.0% |
| 2020 FY | 241.56 Million USD | -30.55% |
| 2020 Q4 | 242.17 Million USD | 0.0% |
| 2019 Q4 | 347.8 Million USD | 0.0% |
| 2019 FY | 347.8 Million USD | 32.59% |
| 2019 Q2 | 368.64 Million USD | 0.0% |
| 2018 FY | 262.32 Million USD | -25.49% |
| 2017 FY | 352.05 Million USD | 100.95% |
| 2016 FY | 175.19 Million USD | 133.25% |
| 2015 FY | 75.11 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 1.87 Million USD | -9158.952% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -34741.365% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -66446.998% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -1547.451% |
| GB Sciences, Inc. | 103.44 Thousand USD | -167986.464% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -1842.887% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -972338.479% |
| Skye Bioscience, Inc. | 11.94 Million USD | -1356.164% |
| Zenith Capital Corp. | 7410.00 USD | -2346350.742% |
| Agentix Corp. | 261.39 Thousand USD | -66417.721% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -8779.225% |
| Biomind Labs Inc. | 73.81 Thousand USD | -235438.276% |
| ContraFect Corporation | 20.67 Million USD | -740.814% |
| CSL Limited | 38.02 Billion USD | 99.543% |
| CytoDyn Inc. | 11.13 Million USD | -1461.351% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -22461.909% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -522.216% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -36081.348% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -240170.849% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -49069.582% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -33.531% |
| SQZ Biotechnologies Company | 107.18 Million USD | -62.214% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -5148.155% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -347.582% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -12041.628% |
| Mesoblast Limited | 667.9 Million USD | 73.967% |
| Marizyme, Inc. | 22.01 Million USD | -689.786% |
| Genus plc | 1.02 Billion USD | 83.101% |
| Pharming Group N.V. | 462.85 Million USD | 62.435% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -27630.781% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -45395.15% |
| IMV Inc. | 31.33 Million USD | -454.903% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -4093.707% |
| MultiCell Technologies, Inc. | 126.22 USD | -137753029.457% |
| ONE Bio Corp. | 70.08 Million USD | -148.086% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -35.298% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -394.249% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -11900.748% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -479.285% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -6231.056% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -25190.988% |
| Alpha Cognition Inc. | 2.45 Million USD | -6990.536% |
| Enzolytics Inc. | 361.7 Million USD | 51.93% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 96.172% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -264.496% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -27082.11% |
| Genscript Biotech Corporation | 3.38 Billion USD | 94.866% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -2308.279% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -227618.26% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -53930.068% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -66424.847% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -18636.994% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -12700.207% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -44440.764% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -18403.143% |
| Helix BioMedix, Inc. | 3.02 Million USD | -5647.671% |
| EV Biologics, Inc. | 431.71 Thousand USD | -40174.812% |
| Q BioMed Inc. | 3.51 Million USD | -4845.844% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -229.922% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 61.042% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 14.56 Million USD | -1094.152% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -6579.174% |
| HST Global, Inc. | 1526.00 USD | -11393871.166% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -7526826.407% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -17498.968% |
| Halberd Corporation | 10.13 Thousand USD | -1716137.291% |
| Resverlogix Corp. | 8.11 Million USD | -2042.6% |
| Cell Source, Inc. | 195.17 Thousand USD | -88987.006% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -763132.518% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 7.37 Million USD | -2256.897% |
| Ember Therapeutics, Inc. | 184.00 USD | -94495552.174% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 62.24 Thousand USD | -279221.424% |
| Kadimastem Ltd | 2.3 Million USD | -7446.266% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -181666.102% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -304436.379% |
| LadRx Corporation | 2.3 Million USD | -7433.834% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -49069.582% |
| Affymax, Inc. | 7.44 Million USD | -2236.047% |
| Itoco Inc. | 1.4 Million USD | -12318.79% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -163930.189% |
| Mobile Lads Corp. | 52.00 USD | -334369130.769% |
| International Stem Cell Corporation | 5.39 Million USD | -3125.826% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | 137.63 Thousand USD | -126225.579% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -121512.623% |
| Qrons Inc. | 420.00 USD | -41397995.238% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -45006.376% |
| SYBLEU INC | 330.46 Thousand USD | -52513.869% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -31391.705% |
| Rebus Holdings, Inc. | 5000.00 USD | -3477340.0% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -42367.674% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -1059.005% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -948.748% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -219991.139% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -20008.318% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -2213.05% |
| Neutra Corp. | 2851.00 USD | -6098532.059% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -436.543% |
| PureTech Health plc | 693.97 Million USD | 74.945% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -2054.257% |
| IXICO plc | 15.84 Million USD | -997.406% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -1999.396% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -68.278% |
| CSL Limited | 38.02 Billion USD | 99.543% |
| Cellectis S.A. | 333.99 Million USD | 47.942% |